Annual report pursuant to Section 13 and 15(d)

RELATED PARTY TRANSACTIONS (Details Narrative)

v3.4.0.3
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Jan. 01, 2016
Oct. 21, 2015
Dec. 20, 2013
Aug. 31, 2014
Feb. 29, 2016
Feb. 28, 2015
Jul. 31, 2012
Share price (in dollars per share)             $ 0.18
Mr. Andrew I. Sealfon [Member] | Lease Agreement [Member] | Aircraft [Member]              
Lease payments         $ 21,500 $ 21,500  
Clinical Research & Support Services Consulting Agreement [Member] | Dr. Paul Mark Baker [Member]              
Amortization of deferred compensation cost         $ 28,000 $ 28,000  
Bonus paid to director       $ 25,000      
Clinical Research & Support Services Consulting Agreement [Member] | FREEDOM60 Syringe Infusion System [Member] | Dr. Paul Mark Baker [Member]              
Number of shares issued upon agreement     420,000        
Share price (in dollars per share)     $ 0.20        
Agreement term     3 years        
Consulting Agreement [Member] | Mr. Cyril Narishkin [Member]              
Monthly payment for agreement $ 16,000 $ 16,000          
Description of payment terms

Seventy-five percent is to be paid in cash and twenty-five percent is to be paid in shares of common stock.

Half is to be paid in cash and half is to be paid in shares of common stock.